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Meta-analysisAbstract Rheumatoid arthritis (RA) is a chronic disease. It causes chronic inflammation of the joint.
Recent studies suggested that interleukin 4 (IL4) contributes to susceptibility and severity of rheumatoid
arthritis (RA). Especially, it was reported that promoter polymorphism (590, T/C) of IL4 gene has
been associated with susceptibility of RA. The aim of present study was to investigate whether the pro-
moter polymorphism (590, T/C) of IL4 gene is associated with the susceptibility of RA using meta-
analysis. And in order to perform meta-analysis, comprehensive meta analysis program was used.
Genetic models (co-dominant, dominant, recessive, and allele) were used to determine odds ratios
(ORs), 95% confidence intervals (CIs), and P values. Nine case-control studies with case and control
designwere included in thismeta-analysis.Overall,meta-analysis revealed a strong associationwith sus-
ceptibility of RA [OR= 1.303, 95% CI= 1.093–1.554, P= 0.003 in allele model (C vs. T);
OR= 1.247, 95% CI = 1.054–1.474, P= 0.010 in dominant model (CC vs. CT+ TT);
OR= 2.148, 95% CI = 1.263–3.651, P= 0.005 in recessive model (CC+ CT vs. TT)]. Our data
demonstrated that promoter polymorphism (590, T/C) of IL4 genemay be contributed to susceptibil-
ity of RA.However,more studies with a larger sample size are needed to providemore precise evidence.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Rheumatoid arthritis (RA) is a systemic inflammatory disorder
and the most common inflammatory arthritis (Lee and
Weinblatt, 2001; Antonisamy et al., 2015). The incidence of
RA in 2008 was estimated to be 42/100,000 in South Korea
(Sung et al., 2013). And the annual incidence in Norway was
28.7/100,000 (Riise et al., 2000) and 44.6/100,000 in Rochester,
Minnesota (Doran et al., 2002).
RA is the most common autoimmune disease. The adap-
tive T-cell response interactions with environmental factors
such as smoking lead to a systemic autoantibody response
and it results in the synovial inflammatory process (Pablos
and Canete, 2013). In these inflammatory responses, many
previous studies investigated the role of genetic factors.
HLA has been regarded as an important genetic factor in
RA risk (Ollier and MacGregor, 1995). IL27 gene
polymorphism was associated with susceptibility of RA in
Chinese (Yan et al., 2015). Recent meta-analysis showed the
association between CCR6 polymorphism and RA (Cheng
et al., 2015).
IL4 gene is located at 5q31.1 and encodes interleukin 4
(http://www.ncbi.nlm.nih.gov). IL4 improves anti-
inflammatory effect and suppresses several pro-inflammatory
cytokines and systemic IL4 treatment protects the cartilage
and bone destruction in established murine type II collagen-
induced arthritis (Joosten et al., 1999). Also, IL4 could be used
for the treatment of RA in association with anti-TNF alpha or
anti-IL1 beta (Meyer, 2003). Genetic polymorphism of IL4
also has an association with RA. IL4 promoter polymorphism
may be a genetic risk factor for RA severity (Pawlik et al.,
2005). Previous study also suggested that the promoter poly-
morphism may be helpful for assessing RA severity (joint ero-
sion and anti-CCP) and TT genotype of polymorphism (590)
showed a significant decrease of IL4 level in serum (Moreno
et al., 2007).
Though the roles of IL4 polymorphisms in RA have been
reported in Chinese (Li et al., 2014) or White participants,
the results has been controversial. In this study, we performed
a meta-analysis on all eligible case-control studies to clarify the
association between IL4 polymorphism (590) and suscepti-
bility to RA.2. Materials and methods
2.1. Search strategy and data extraction
We firstly found the meta-analysis studies between IL4-590
polymorphism and RA. And electronic database including
pubmed, embase, google of scholar, and Korean Studies Infor-
mation Service System (KISS) were investigated up to June
2015. In order to select eligible studies about IL4-590 polymor-
phism and RA. The keywords to find eligible studies were
used: ‘‘interleukin 4”, ‘‘IL4‘‘, or ‘‘cytokine”, AND ‘‘polymor-
phism” or ‘‘SNP” AND ‘‘590” or ‘‘rs2243250‘‘ AND ‘‘RA”.
The data of first author’s name, year of publication, country,
sample size of RA and control, genotype frequencies of IL4-
590 polymorphism in RA and control were extracted from
the final selected studies.
2.2. Inclusion criteria
Studies were included if they met the following criteria: (1)
evaluated the association between the IL4 polymorphism
(590, T/C) and RA; (2) used a case-control study design;
(3) contained sufficient published data for the estimation of
an odds ratio (OR) with a 95% confidence interval (CI).
2.3. Statistical analysis
Hardy–Weinberg equilibrium (HWE) in the control group of
include studies was evaluated by the Chi-square test.
Meta-analysis and sensitivity analysis were used by the
Comprehensive Meta-analysis software (Corporation, NJ,
USA). The pooled p value, OR, and 95%CI were used to assess
the strength of association between risk of RA and IL4-590
polymorphism (Kim et al., 2013; Seok et al., 2014). The
meta-analysis was performed while omitting each study one at
a time to examine the influence of each study on the pooled
OR. In order to assess heterogeneity among the studies, a
v2-test-based Q statistic test and I squared test were done.
The random-effects Mantel–Haenszel method was adopted if
the result of the Q test was P< 0.05 or I squared value
was >50%, which indicated the statistically significant
heterogeneity between the studies. Otherwise, the fixed-effects
Table 1 Characteristics of eligible studies included in the meta-analysis.
Study Country RA/Control (n) Genotyping method RA Control RA Control HWE in control
C/C C/T T/T C/C C/T T/T C T C T
Trajkov et al. (2009) Macedonia 85/286 Sequencing 47 37 1 95 187 4 131 39 377 195 <0.001
Nun˜ez et al. (2008) Spain 599/540 TaqMan 398 179 22 375 155 10 975 223 905 175 0.185
Moreno et al. (2007) Colombian 102/102 PCR-RFLP 39 48 15 49 48 5 126 78 146 58 0.11
Pawlik et al. (2005) Poland 94/102 PCR-RFLP 62 28 4 74 26 2 152 36 174 30 0.87
Plenge et al. (2005) Sweden 1503/875 Sequenom 940 507 56 584 253 38 2387 619 1421 329 0.12
Plenge et al. (2005) North America 835/847 Sequenom 594 219 22 571 254 22 1407 263 1396 298 0.38
Cantagrel et al. (1999) France 107/68 PCR-RFLP 63 41 3 82 36 0 167 47 200 36 0.05
Emonts et al. (2011) Netherland 372/460 Sequencing 267 91 14 339 112 9 625 119 790 130 0.94
Hussein et al. (2013) Egypt 172/172 PCR-RFLP 96 56 20 123 46 3 248 96 292 52 0.58
Li et al. (2014) China 752/798 PCR-RFLP 481 218 53 575 207 16 1180 324 1357 239 0.60
Canet et al. (2015) Spain 1239/1229 KASPar 859 325 34 863 275 34 2043 393 2001 343 0.037
RA= rheumatoid arthritis, n= number of subjects.
Bold number indicates significant difference.
Table 2 Overall analysis between IL4-590 polymorphism and susceptibility of RA in nine studies.
Genetic comparison Association Heterogeneity Model Publication bias
OR (95% CI) P P I2 Egger’s test
C vs. T 1.303 (1.093–1.554) 0.003 <0.001 75.46 Random 0.18
C/C vs. C/T + T/T 1.247 (1.054–1.474) 0.010 0.006 62.75 Random 0.22
C/C + C/T vs. T/T 2.148 (1.263–3.651) 0.005 <0.001 72.26 Random 0.09
C/C vs. C/T 1.128 (1.025–1.241) 0.014 0.100 40.28 Fixed 0.37
C/C vs. T/T 2.272 (1.313–3.931) 0.003 <0.001 73.55 Random 0.10
Rheumatoid arthritis (RA), odds ratio (OR), confidence interval (CI), number of subjects (n).
Bold numbers indicate significant association with RA.
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and Egger’s test were performed to evaluate publication bias.
For sensitivity analysis, the meta-analysis was performed sub-
tracting each study to examine the influence of each study over
and over again. The P< 0.05 was regarded as statistically
significant.
3. Results
The present study performed the meta-analysis to assess rela-
tionship between promoter polymorphism (590, T/C) of
IL4 gene and susceptibility of RA. Firstly, searching was con-
ducted to find related studies from electronic databases accord-
ing to search strategy. Eleven case and control studies about
promoter polymorphism (590, T/C) of IL4 gene polymor-
phism (Ser326Cys) and susceptibility of RA were searched
(Canet et al., 2015; Cantagrel et al., 1999; Emonts et al.,
2011; Hussein et al., 2013; Li et al., 2014; Nunez et al., 2008;
Moreno et al., 2007; Pawlik et al., 2005; Plenge et al., 2005;
Trajkov et al., 2009). Among these studies, six studies
(Cantagrel et al., 1999; Pawlik et al., 2005; Moreno et al.,
2007; Nunez et al., 2008; Trajkov et al., 2009; Hussein et al.,
2013) were analyzed by meta-analysis in 2013 (Song et al.,
2013). However, there was an error in data by the meta-
analysis in 2013. Song et al., 2013 reported results of meta-
analysis between promoter polymorphism (590, T/C) of
IL4 gene and susceptibility of RA. They included the data
from the study (Cantagrel et al., 1999) in the meta-analysis
They summarized that the genotype frequencies (C/C:C/T:T/T) of promoter polymorphism (590, T/C) of IL4 gene in
the control group were 32:36:0, but original data of the study
(Cantagrel et al., 1999) is 82:36:0. In meta-analysis between
specific polymorphisms and susceptibility of diseases, it was
important to search eligible studies and extract exact data.
So, this updated meta-analysis was performed.
Table 1 shows characteristics of eligible studies included in
the meta-analysis. The first author’s name, year of publication,
country, sample size, and genotype frequencies of IL4-590 poly-
morphism in RA patients and controls were extracted. Among
eleven studies, studies by Trajkov et al., 2009 and Canet et al.,
2015 were excluded in the meta-analysis because HWEs of
genotype distribution of IL4-590 polymorphism in the control
group was p< 0.05. Table 2 and Fig. 1 presents the results of
meta-analysis between IL4-590 polymorphism and susceptibil-
ity of RA in nine studies. In all models, IL4-590 polymorphism
revealed the significant association with susceptibility of RA
(random model, OR = 1.303, 95% CI = 1.093–1.554,
P= 0.003 in allele; random model, OR = 1.247, 95%
CI = 1.054–1.474, P= 0.010 in dominant; random model,
OR = 2.148, 95% CI = 1.263–3.651, P= 0.005 in recessive;
Fixed model, OR = 1.128, 95% CI = 1.025–1.241, P= 0.014
in codominant 1; Random model, OR = 2.272, 95%
CI = 1.313–3.931, P= 0.003 in codominant 2). Sensitivity
analysis confirmed the stability of the results of meta-analysis
(data not shown) and no publication bias was found in the pre-
sent meta-analysis. These results indicate that promoter poly-
morphism (590, T/C) of IL4 gene polymorphism is related
to susceptibility of RA (Table 2 and Fig. 1).
Figure 1 Odds ratio and 95% CI of individual and pooled data for the IL4 polymorphism (590) and susceptibility of RA. A: C allele
vs. T allele; B: C/C genotype vs. C/T genotype + T/T genotype; C: C/C genotype + C/T genotype vs. T/T genotype.
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Many factors such as gene, cytokine, inflammatory mediators,
adhesion molecules, and so on involve in the pathophysiology
of RA. Among them, many genetic factors have been identified
due to advances in genetic methods (Lee and Weinblatt, 2001).
In this study, we focused on the genetic factor of RA and car-
ried out meta-analysis to investigate the relation between IL4
polymorphism and the risk of developing RA.In the present study, we could find significant associations
in allele, dominant, and recessive models. The results of this
meta-analysis are consistent with the results of a previous
meta-analysis (Canet et al., 2015). Among these, only the
study by Li et al. (2014) involves Asian population (Chinese).
According to NCBI database, genotype frequency in Chinese
is 0.023 (C/C), 0.395 (C/T), and 0.581 (T/T) and allele fre-
quency in Chinese is 0.221 (C) and 0.779 (T). On the other
hand, genotype and allele frequencies in White are definitely
448 H.K. Park et al.different. According to NCBI database, genotype frequency
in European is 0.743 (C/C), 0.239 (C/T), and 0.018 (T/T)
and allele frequency in Chinese is 0.863 (C) and 0.137 (T).
As shown in Table 1, genotype and allele frequencies in pre-
vious studies are similar to those in NCBI database. Interest-
ingly, the genotypes and allele frequencies in 2014 by Li et al.
(2014) are similar to those of European rather than those of
Asian according to NCBI database. Previous study reported
that the incidence and prevalence of RA showed different
trends according to ethnicity. In Korea, the prevalence of
RA in 2008 was estimated to be 0.27% (Sung et al., 2013).
One study on rural African had found only 14 cases of
RA in about 520,000. The prevalence of RA was 0.0026%
(Brighton et al., 1988). In contrast, the prevalence of RA
in a Chippewa Band (American Indian) reached to 5.3–
6.8% (Harvey et al., 1981). A study in Norway reported that
the prevalence of RA was 0.47% in 1994 (Riise et al., 2000).
In United Kingdom, the prevalence of RA is 1.16% in
women and 0.44% in men (Symmons et al., 2002). The
prevalence of RA in the urbanized Chinese of Hong Kong
was 0.35% (Lau et al., 1993). Thus, previous studies showed
the significant geographic variations of RA occurrence and
difference of prevalence according to ethnicity. These results
suggest an association of RA with ethnicity and genetic
factors.
5. Conclusion
In conclusion, our meta-analysis study showed that IL4
polymorphism was associated with RA. However, the limita-
tion of our study is that there was not enough data on other
ethnicities. We could not find the studies on African popu-
lation and the number of studies on Asian was only one.
In spite of these limitation, our meta-analysis provided evi-
dence of the association between IL4 polymorphism and risk
of RA. It is well known that early diagnosis and treatment
of RA could lead to favorable outcomes. Therefore, early
diagnosis and preventive treatment by detecting the suscepti-
bility to RA in gene level would play a major role in
improving the prognosis of RA. Many previous association
studies revealed the association between IL4 polymorphism
and RA and our present meta-analysis strengthened the rela-
tionship. If further studies will be performed in more popu-
lation, promoter polymorphism (590, T/C) of IL4 gene
could be a useful marker for the early diagnosis and treat-
ment of RA.
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